Add to Favorites Newsroom RSS Share
Boston, MA USA

Our News on Newswise

Dana-Farber/Brigham and Women’s physician wins prestigious 2017 William Dameshek Prize from the American Society of Hematology

• Benjamin Ebert, MD, PhD, current chair of Medical Oncology, was presented with recognition at annual American Society of Hematology meeting • Ebert is notable for his leadership in describing the genomic landscape of adult myelodysplastic...
7-Dec-2017 2:30 PM EST Add to Favorites

Study Identifies Agent That Can Reverse Resistance to Targeted Drug in Some Leukemia Cell Types

• Azacitidine reverses resistance to SL-401 in AML and BPDCN cell lines, researchers find • Results prompt clinical trial of SL-401 and azacitidine in AML and MDS patients
7-Dec-2017 2:30 PM EST Add to Favorites

Study Shows Combining Chemotherapy with Targeted Drug Boosts Response in Chronic Lymphocytic Leukemia

Among younger patients newly diagnosed with chronic lymphocytic leukemia (CLL), treatment with a combination of chemotherapy and a molecularly targeted drug significantly improves response over what is typically seen with chemotherapy alone,...
7-Dec-2017 2:25 PM EST Add to Favorites

Sequencing Offers Clues to Progression Toward Multiple Myeloma

Researchers at Dana-Farber Cancer Institute have carried out the largest genomic analysis of patients with smoldering multiple myeloma (SMM), a precursor to full-blown blood cancer that doesn’t show outward symptoms.
7-Dec-2017 2:30 PM EST Add to Favorites

Tracking How Multiple Myeloma Evolves by Sequencing DNA in the Blood

Although people with multiple myeloma usually respond well to treatment, the blood cancer generally keeps coming back. Following genetic changes in how the disease evolves over time will help to understand the disease and, eventually, deliver more...
7-Dec-2017 2:20 PM EST Add to Favorites

Rapid Responses, Few Adverse Effects Seen with Targeted Agent in Phase 1 Trial in Rare Blood Disorder

• Clinical Activity in a Phase 1 Study of BLU-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis • Study shows one of multiple ways in which novel targeted cancer therapies are now being deployed to...
7-Dec-2017 2:00 PM EST Add to Favorites

Low-Dose Treatment with Interleukin-2 Across Multiple Studies Shows Benefits in Chronic Graft-Versus-Host Disease

Daily low doses of the immune signaling protein interleukin-2 (IL-2) can safely benefit patients who develop chronic graft-versus-host disease following stem cell transplants, including particular benefit in pediatric patients in one small study,...
7-Dec-2017 2:15 PM EST Add to Favorites

Study Explores Use of Checkpoint Inhibitors After Relapse From Donor Stem Cell Transplant for Hematologic Cancers

Immunotherapy agents known as checkpoint inhibitors have shown considerable promise in patients with hematologic cancers who relapse after a transplant with donor stem cells. Preliminary results from the first clinical trial in these patients of one...
7-Dec-2017 2:15 PM EST Add to Favorites

Our Experts on Newswise

Colorectal Cancer: Five Things You Need To Know

Dr.JeffreyMeyerhardtFINAL.jpg

With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST

Leading Breast Cancer Expert Available to Comment on Young Women with Breast Cancer

AnnPartridge.jpg

11-Nov-2013 5:00 PM EST

National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support

PF_SOG_7837.jpg

17-Sep-2013 3:00 PM EDT

Vaccinating Children Against HPV?

Dr.Haddadphoto.jpg

The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT

Prophylactic Double Mastectomy: Angelina Makes a Private Choice a Public Issue

Andrea_Patenaude.jpg

24-May-2013 3:00 PM EDT

News Tip: New Research on Teenage Girls and Melanoma Makes This the Season for Tanning Stories

Carlos_Rodriguez-Galindo_SOG_6619_09.jpg

Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT

Healthy Holiday Helpings: Experts Offer Tips to Fight Cancer with Your Fork This Holiday Season

The holidays are almost here and festive food is everywhere. “While these foods are delicious to eat, some have the added bonus of containing cancer-preventing nutrients,” says Stephanie Meyers, MS, RD/LDN, a nutritionist at Dana-Farber Cancer...
23-Oct-2009 1:00 PM EDT

Our YouTube Videos





Chat now!